Moreover, unlike in hypoparathyroidism, the intact anti-calciuric action of PTH in the thick ascending limb is unaffected in PHP, leading to a reduced risk of hypercalciuria, even with aggressive calcium and vitamin D therapy [4]. This evidence concerns the gene PTH and hypoparathyroidism.